معرفی
Janine Erler is a Professor and Group Leader at the Biotech Research and Innovation Center (BRIC), University of Copenhagen. She has held academic positions at the Institute of Cancer Research (London) and Stanford University, where she established her expertise in hypoxia-regulated cancer biology and metastasis.
- Education:
- PhD in Molecular Pharmacology (University of Manchester, 2003)
- BSc (Hons) in Molecular Genetics (University of Sussex, 2000)
- European Baccalaureate (The European School, 1996)
Her research focuses on cancer biology and translational research, particularly mechanisms of metastasis, hypoxia-induced drug resistance, and extracellular matrix (ECM) remodeling. Recent work explores ECM stiffness, LOX enzyme function, and fibroblast-cancer cell interactions in metastatic progression.
Key publications include studies on lysyl oxidase in cholangiocarcinoma, angiocrine signaling in cancer targeting, and machine learning analysis of ECM patterns. Her work frequently intersects computational biology, cancer metabolism, and stromal remodeling.
Scientific awards:
- BACR Translational Research Award (2009)
- BACR/AstraZeneca Young Scientist Frank Rose Award (2012)
- Novo Nordisk Hallas Møller Stipendum (2012) - first woman to receive this award
